Healthcare - Biotechnology - NASDAQ - US
$ 26.27
-6.38 %
$ 3.27 B
Market Cap
-13.0
P/E
CASH FLOW STATEMENT
-595 M
OPERATING CASH FLOW
-674 K
INVESTING CASH FLOW
394 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Apellis Pharmaceuticals, Inc.
| Net Income | -529 M |
| Depreciation & Amortization | 1.7 M |
| Capital Expenditures | -773 K |
| Stock-Based Compensation | 106 M |
| Change in Working Capital | -200 M |
| Others | -174 M |
| Free Cash Flow | -596 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (528.6) | (652.2) | (746.4) | (344.9) | (304.7) | (127.5) | (51.0) | (27.1) | (46.5) | (10.8) | (4.0) |
| Depreciation & Amortization | 1.7 | 1.5 | 1.5 | 0.6 | 0.2 | 0 | 11.9 K | 0 | 0 | 6.59 K | 6.26 K |
| Deferred Income Tax | 0 | 0 | 198.3 | 103.0 | 16.3 | 0 | 0.2 | 0 | 0 | 0 | (0.3) |
| Stock Based Compensation | 105.9 | 91.1 | 70.7 | 45.4 | 21.1 | 7.7 | 5.4 | 1.1 | 0.5 | 0.7 | 0.3 |
| Other Operating Activities | 26.4 | 61.6 | 6.3 | 15.8 | 2.7 | 0.6 | 13.6 K | 1.0 | 26.5 | 804 | 0.3 |
| Change in Working Capital | (200.2) | (15.7) | (93.5) | 19.6 | 53.1 | (12.0) | (1.2) | 42.6 K | 0.6 | 0.2 | 0.2 |
| Cash From Operations | (594.7) | (513.7) | (563.1) | (160.5) | (211.1) | (131.2) | (46.6) | (26.0) | (18.9) | (9.9) | (3.4) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (0.8) | (1.5) | (1.1) | (5.4) | (1.7) | 0 | 0 | 0 | 0 | 19.9 K | 0 |
| Other Items | 99 K | 61.4 | 248.7 | (311.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.7) | 59.9 | 247.6 | (317.0) | (1.7) | 0 | 0 | 0 | 0 | 19.9 K | 0 |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 322.9 | 184.2 | 0 | 26.4 | 0 | 0 | 0 | (0.3) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 10.1 | (14.5) | 11.9 | 369.3 | 204.3 | 0.7 | 20.9 | 14.9 | 41.2 | 18.8 | 7.4 |
| Cash From Financing Activities | 394.5 | 365.7 | 392.2 | 692.2 | 388.5 | 131.9 | 197.4 | 14.9 | 41.2 | 18.8 | 7.2 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (200.8) | (88.7) | 74.7 | 215.1 | 175.7 | 0.6 | 150.8 | (11.1) | 22.4 | 8.9 | 3.7 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (595.5) | (515.3) | (564.2) | (165.9) | (212.8) | (131.2) | (46.6) | (26.0) | (18.9) | (10.0) | (3.4) |